Article Details
Retrieved on: 2024-09-04 22:12:40
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Grzegorz S. Nowakowski, MD, discusses results from the EPCORE NHL-1 trial of third-line epcoritamab in relapsed/refractory follicular lymphoma.
Article found on: www.onclive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here